Precision outcomes research: Shaping the future of oncology biopharma with real-world evidence

Delve into the evolving landscape of outcomes research with a focus on real-world evidence (RWE) and advanced analytics.

Watch replay

An algorithmic approach to close care gaps for patients that may benefit from confirmatory IHC HER2 testing

In partnership with a global pharmaceutical company, Tempus Next deployed a HER2 predictive algorithm at selected sites within the Tempus network. This algorithm was used during routine xR (whole transcriptome RNA) tests to identify patients who may benefit from additional confirmatory IHC HER2 testing.

Read more

Navigating complex cell therapy trials with Compass CRO

Learn how Compass provided CRO services for a biotech’s first-in-human, dose-escalation, and expansion basket trial targeting advanced solid tumors.

Read more